Carbapenem-susceptible and -resistant strains of Acinetobacter from the ARLG's PRIMERS3 study. Results from molecular diagnostic assays and genome sequences will be compared with phenotypic results to
BackgroundAcinetobacter sp. has emerged as a significant pathogen causing nosocomial infections. Treatment of these pathogens has become a major challenge to all clinicians worldwide. Huge revenue and